Association between the response to B cell depletion therapy and the allele2 of the HS1,2A enhancer...
Association between the response to B cell depletion therapy and the allele2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients Association between the response to B cell depletion therapy and the allele2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients
About this item
Full title
Author / Creator
D. Frezza , B. Tolusso , E. Serone , M.C. Totaro , S. Canestri , E. Gremese and G. Ferraccioli
Publisher
PAGEPress Publications
Journal title
Language
English
Formats
Publication information
Publisher
PAGEPress Publications
Subjects
More information
Scope and Contents
Contents
Objective. Several studies underline the relevance of the genetic background for the response to therapy. We evaluated the relationship between the polymorphism of the HS1,2A enhancer, located in the 3’ regulatory region of the heavy immunoglobulin chain (IgH), and the response to B cell depletion therapy (BCDT) with Rituximab (RTX). Methods. Fifty...
Alternative Titles
Full title
Association between the response to B cell depletion therapy and the allele2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients Association between the response to B cell depletion therapy and the allele2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_bb08af493f5d4ac3b4d7ff3265b561a4
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bb08af493f5d4ac3b4d7ff3265b561a4
Other Identifiers
ISSN
0048-7449
E-ISSN
2240-2683
DOI
10.4081/reumatismo.2012.368
